Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
Food and Cosmetics Toxicology
|
October 1, 1978
Carcinogenic risk estimation for chloroform: an alternative to EPA's procedures
R H Reitz, P J Gehring, C N Park
The Journal of Pharmacy and Pharmacology
|
October 1, 1972
A comparison of Mg pemoline and (+)-amphetamine effects upon avoidance behaviour and the amine pump
R H Reitz, S E Bocknik, A S Kulkarni
The Journal of Biological Chemistry
|
April 7, 1995
A conformation-specific anti-peptide antibody to the beta-type platelet-derived growth factor receptor also recognizes the activated epidermal growth factor receptor
K Panneerselvam, H Reitz, S A Khan, et al.
Toxicology and Applied Pharmacology
|
February 1, 1989
In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models
R H Reitz, A L Mendrala, F P Guengerich
Transplantation Proceedings
|
December 1, 1974
Evaluation of the efficiency of leukocyte transfers by Y-chromatin studies
K P Hellriegel, H Borberg, H Reitz, et al.
Regulatory Toxicology and Pharmacology : RTP
|
December 1, 1988
Toxicokinetics in the evaluation of toxicity data
P G Watanabe, A M Schumann, R H Reitz
Toxicology
|
October 28, 1996
Using PBPK modeling and comprehensive realism methodology for the quantitative cancer risk assessment of butadiene
R L Sielken, R H Reitz, S M Hays
Basic Life Sciences
|
January 1, 1986
The role of pharmacokinetics in risk assessment
R H Reitz, T R Fox, P G Watanabe
Journal De Toxicologie Clinique Et Experimentale
|
January 1, 1988
Mechanistic considerations in carcinogenic risk estimation
P G Watanabe, R H Reitz, A M Schumann
Advances in Experimental Medicine and Biology
|
January 1, 1981
Translation of pharmacokinetic/biochemical data into risk assessment
F K Dietz, R H Reitz, P G Watanabe, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
Food and Cosmetics Toxicology
|
October 1, 1978
Carcinogenic risk estimation for chloroform: an alternative to EPA's procedures
R H Reitz, P J Gehring, C N Park
The Journal of Pharmacy and Pharmacology
|
October 1, 1972
A comparison of Mg pemoline and (+)-amphetamine effects upon avoidance behaviour and the amine pump
R H Reitz, S E Bocknik, A S Kulkarni
The Journal of Biological Chemistry
|
April 7, 1995
A conformation-specific anti-peptide antibody to the beta-type platelet-derived growth factor receptor also recognizes the activated epidermal growth factor receptor
K Panneerselvam, H Reitz, S A Khan, et al.
Toxicology and Applied Pharmacology
|
February 1, 1989
In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models
R H Reitz, A L Mendrala, F P Guengerich
Transplantation Proceedings
|
December 1, 1974
Evaluation of the efficiency of leukocyte transfers by Y-chromatin studies
K P Hellriegel, H Borberg, H Reitz, et al.
Regulatory Toxicology and Pharmacology : RTP
|
December 1, 1988
Toxicokinetics in the evaluation of toxicity data
P G Watanabe, A M Schumann, R H Reitz
Toxicology
|
October 28, 1996
Using PBPK modeling and comprehensive realism methodology for the quantitative cancer risk assessment of butadiene
R L Sielken, R H Reitz, S M Hays
Basic Life Sciences
|
January 1, 1986
The role of pharmacokinetics in risk assessment
R H Reitz, T R Fox, P G Watanabe
Journal De Toxicologie Clinique Et Experimentale
|
January 1, 1988
Mechanistic considerations in carcinogenic risk estimation
P G Watanabe, R H Reitz, A M Schumann
Advances in Experimental Medicine and Biology
|
January 1, 1981
Translation of pharmacokinetic/biochemical data into risk assessment
F K Dietz, R H Reitz, P G Watanabe, et al.
Page
of 5